Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This synthetic peptide duplicates the actions of naturally occurring GLP-1, a hormone that plays a crucial role in managing blood glucose levels. By stimulating GLP-1 receptors in the pancreas, Retasturtide increas… Read More